- Introduction and Program Overview
- Key Findings From CROI 2018
- Targeted PrEP
- Rapid ART Initiation
- Switching ART in Suppressed Patients
- ART and CVD Risk
- Investigational Agents and Strategies
- INSTI Intensification of First-line ART in Immunocompromised Patients
- ART Use With TB Therapy
- HIV and Pregnancy
- Question and Answer Session
Date / Time
Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Babafemi Taiwo, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
New in 2018! In this engaging Webinar, expert faculty review data presented at CROI and how key findings integrate into existing best practices, highlighting the most important resultant changes to their own patient management.
The goal of this activity is to improve participants’ competence in providing optimal care for HIV-infected patients.
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for HIV-infected patients.
- Incorporate the results of recent clinical studies that appropriately reflect the latest findings when utilizing antiretroviral agents for treatment-naive or treatment-experienced patients with HIV infection
- Provide insightful counsel to patients and colleagues regarding studies of investigational antiretroviral agents and strategies in advanced stages of development
- Apply data from studies investigating health outcomes in HIV-infected patients with comorbidities or coinfections
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine, the Annenberg Center and Clinical Care Options. The Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this live meeting for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program has been assigned ACPE Universal Activity #0797-9999-18-056-L02-P. This program is designated for up to 2.5 contact hours (0.25 CEUs) of continuing pharmacy education credit.
Type of Activity: Knowledge
Nursing Continuing Education
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
2.5 contact hours may be earned for successful completion of this activity.
Disclosure of Conflicts of Interest
The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
The Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine have no conflict of interest with commercial interests related directly or indirectly to this educational activity.
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Peer Reviewer: Barry S. Zingman, MD, Medical Director, AIDS Center; Clinical Director, Infectious Diseases, Moses Division; and Professor of Clinical Medicine at Albert Einstein College of Medicine has no real or apparent conflicts of interest to report.